Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia

Allogeneic natural killer (NK) cell-based immunotherapy is a promising, well-tolerated adjuvant therapeutic approach for acute myeloid leukemia (AML). For reproducible NK cell immunotherapy, a homogenous, pure and scalable NK cell product is preferred. Therefore, we developed a good manufacturing pr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jonge, P. K. J. D., van Hauten, P. M. M., Janssen, L. D., de Goede, A. L., Berrien-Elliott, M. M., van der Meer, J. M. R., Mousset, C. M., Roeven, M. W. H., Foster, M., Blijlevens, N., Hobo, W., Fehniger, T. A., Jansen, J. H., Schaap, N. P. M., Dolstra, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491545/
https://www.ncbi.nlm.nih.gov/pubmed/37477653
http://dx.doi.org/10.1007/s00262-023-03492-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491545/
https://www.ncbi.nlm.nih.gov/pubmed/37477653
http://dx.doi.org/10.1007/s00262-023-03492-6

Ejemplares similares